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Malfunction of the autonomic nervous system 
has been implicated in atopic dermatitis for many 
years. Perhaps the best known abnormalities are 
white dermographism [1] and the delayed blanch 
phenomenon [2] which have generally been consid-
ered to be due to excessively vigorous vasoconstric-
tion. Indeed, vasoconstriction in the digital arteries 
as well as the skin is regularly evident in patients 
with atopic dermatitis [3]. Juhlin [4] reported that 
not only arteriolar but also pilomotor smooth 
muscle is abnormally sensitive to alpha adrenergic 
agonists. There is also exaggerated sensitivity of 
the sweat glands to acetylcholine [5]. Propranolol, 
a beta antagonist, enhances acetylcholine stimula-
tion in the sweat glands of normal but not atopic 
subjects [6]. 
The mechanism of these abnormalities and their 
significance in the pathogenesis of atopic dermati-
tis remain uncertain. Szentivanyi [7] proposed 
that the various abnormalities of atopic diseases 
could be explained by postulating a partial block of 
the beta adrenergic receptor sites of the cells 
involved. Thus, both the increased sensitivity of 
the vascular and pilomotor smooth muscle to alpha 
adrenergic stimulation and the increased sensitiv-
ity of the sweat glands to acetylcholine would be 
predicted if the full normal counterbalancing effect 
of beta adrenergic stimulation were lacking. The 
lack of response of sweat glands of patients with 
atopic dermatitis to propranolol might occur 
because the beta receptors were already blocked. 
Plausible, but untested, extensions of this hypoth-
esis would explain the decreased threshold of 
cutaneous itching by reduced beta receptor activ-
ity of cutaneous neurons with resulting heightened 
excitability. In other neurons McAfee and Green-
gard [8] found that increase of intracellular 3',5'-
cyclic adenosine monophosphate (cAMP) in re-
sponse to adrenergic agonists increases the thresh-
old of excitability. Increased levels of IgE might be 
the result of decreased adrenergic activity that 
ordinarily modulates one of the steps in the IgE 
antibody response. Adrenergic agonists have been 
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found to decrease and antagonists to increase the 
homocytotropic antibody response in rats [9]. A 
pronounced tendency to lichenification, another 
characteristic feature of atopic dermatitis, strongly 
suggests abnormal proliferation of epidermal cells 
in response to scratching. Bullough [10,11] demon-
strated that epidermal mitosis is inhibited by beta 
adrenergic stimulation; and Voorhees, Duell, and 
Kelsey [12] added that epidermal mitosis is inhib-
ited by cAMP, so that the hypothetical decreased 
beta adrenergic response could account for the 
lichenification. 
Interpretation of physiologic or pharmacologic 
studies of possible mechanisms of vascular and 
other autonomic abnormalities carried out in vivo 
is rendered virtually impossible by the complexity 
of the mechanisms that maintain homeostasis. 
Some of these variables can be controlled in 
studies on isolated tissues. 
Our first in vitro experiments to test the beta 
adrenergic blockade hypothesis in atopic dermati-
tis employed a sheet of epidermis approximately 20 
x 70 x 0.3 mm [13]. This was removed with a 
keratotome from an area of lichenified skin (the 
volar surface of the forearm) and an area of 
normal-appearing skin (the lateral surface of the 
thigh) in patients with atopic dermatitis and from 
similar areas in normal subjects. The preparation, 
which contained the full thickness of the epidermis 
and a thin part of dermis, was cut into repli-
cate samples of equal area and cultured with 
[3H ]thymidine in Medium 199 supplemented by 
20% autologous plasma. Catecholamines were 
added at the start of the culture and replenished at 
24 hr. The cultures were harvested at 48 hr and the 
incorporation of tritiated thymidine determined. 
We found no difference in DNA synthesis in the 
control tubes without added catecholamines 
between the patients with dermatitis and the 
normal subjects. The skin of patients with e'czema, 
however, showed greater DNA synthesis in the 
epidermis obtained from the arm, where the dis-
ease was active, then in epidermis from the thigh 
where the skin appeared normal. The DNA synthe-
sis in normal arm skin was also slightly more active 
than normal leg skin. 
Catecholamines inhibited DNA synthesis in nor-
mal epidermis from both the arm and the leg. 
Comparison of the dose-response curves indicates 
that isoproterenol is about 10-fold more potent 
than epinephrine and 100-fold more potent than 
norepinephrine (Fig. la). In contrast, the cate-
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cholamines had no effect on DNA synthesis of 
either lichenified or normal-appearing skin from 
patients with eczema (Fig. Ib). 
The decreased effect of the catecholamines was 
not due to increased destruction by catechola-
mine-O-methyl transferase or other enzymes by 
the eczematous skin, for there was no difference in 
the rate of disappearance of epinephrine from the 
culture fluid. 
In epidermis, as in other tissues, beta adrenergic 
stimulation increases intracellular levels of cAMP 
[14]. cAMP inhibits epidermal cell division [12]. It 
was thus of interest to compare the effect of beta 
agonists on the levels of cAMP in epidermal sheets 
stripped from normal and atopic subjects [15]. In 
normal subjects a 1.0 J.LM concentration of iso-
proterenol evokes a nearly maximal response (Tab. 
1). Although resting levels of cAMP were higher in 
atopic than normal skin, the response to iso-
proterenol was similar (Tab. II). 
At this point our data confirmed previous reports 
that mitosis of basal cells was inhibited by beta 
adrenergic stimulation and added that this inhibi-
tion was impaired in atopic dermatitis but indi-
cated that beta adrenergic stimulation of adenyl 
cyclase in the atopic skin slices was normal. At 
least three interpretations of these data can be 
considered. First, the defective step in the chain of 
biochemical reactions that link adrenergic receptor 
activation to inhibition of mitosis lies subsequent 
to the activation of adenyl cyclase. Second, inas-
much as this preparation cont:::;"s several cell 
types, it is possible that reduced response of adenyl 
cyclase of basal cells is obscured by a normal 
response of the much larger number of other cells. 
Alternately, it is possible that mitosis is controlled 
by an adenyl cyclase on the nuclear membrane of 
basal cells that is relatively unresponsive to beta 
agonists but thc...~ plasma membrane adenyl cyclase 
responds normally. Wedner et al [16] have reported 
that isoproterenol and prostaglandin El (PGE 1) 
give different patterns of localization of intracellu-
lar increases of '~AMP in human lymphocytes and 
that isoproterenol, but not PGEI, stimulated ade-
nyl cyclase of isolated nuclei. Third, the initial 
elevated levels of cAMP may be high enough to 
inhibit the DNA synthesis maximally so that 
further increase of cAMP by catecholamines has no 
additional inhibitory effect. Resolution among the 
possibilities requires further in vitro studies on a 
homogeneous preparation of single cell types. The 
experimental conditions should also provide suffi-
cient numbers of cells to allow analysis of the steps 
in the chain of biochemical reactions that link 
receptor activation to the ultimate physiologic 
response. Many technical difficulties limit the 
feasibility of isolating sufficient numbers of intact 
basal cells and led us to choose 'peripheral blood 
leukocytes for the next phase of the investigation. 
Logsdon et al [17] and Parker and Smith [18] 
reported that leukocytes, primarily lymphocytes, 
of asthmatic patients have diminished adenyl 
cyclase response to beta adrenergic agonists. 
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FIG. 1. Catecholamine inhibition of DNA synthesis by 
epidermis of normal subjects . Mean and SEM of 10 
subjects. At the maximal effective dose DNA synthesis 
was inhibited about 50%. Isoproterenol is about 10 times 
more effective than epinephrine and about 100 times 
more effective than norepinephrine. a: Biopsies of the 
skin of the forearm of normal subjects. b: Biopsies of 
forearms of Datients with atopic dermatitis. (Reprinted 
from J Allergy Clin Immunol51:258, 1973.) 
Although treatment with adrenergic drugs haf. 
been found to produce such a diminished response 
[19], the diminished leukocyte response does occur 
in patients who have not recently received adrener-
gic drugs ([18]; Busse and Lee, unpublished data). 
Furthermore, Parker and Eisen [20] found that 
maximal concentrations of isoproterenol increased 
cAMP concentrations 5-fold in leukocytes of nor-
mal subjects but only 2-fold in leukocytes of 
patients with atopic dermatitis. With the demon-
stration by Buckley [21] that some patients with 
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atopic dermatitis have abnormal lymphocyte func-
tion, and of Hill and Quie [22] that some have 
defective neutrophil granulocyte chemotaxis, we 
considered that sufficient evidence exists for ab-
normalities in the function of lymphocytes and 
neutrophilic granulocytes to encourage use of puri-
fied leukocyte preparations in our investigations. 
TABLE I. Effect of cat echola mines on cAMP content 
in human epidermisa 
Addition 
None (control) 
1-Isoproterenol 
1-Epinephrine 
I-Norepinephrine 
0.1 p.M 
1.0 p.M 
10.0 p.M 
100.0 p.M 
1.0p.M 
1.0 p.M 
cAMP 
(pmoles/mm 3 
epidermis) 
0.22 
0.41 
1.49 
l.71 
l.59 
0.93 
0.50 
Each value represents average of 2 samples from one 
person. Each sample was analyzed in duplicate. 
a Reprinted from J Allergy Clin ImmunoI53:284, 1974 
[15 ] 
TABLE II. Comparison of cAMP content and adenyl 
cyclase response of normal and atopic epidermisa 
cAMP (pmoles/mm 3 epidermis)" 
Addition 
None 
Isoproterenol 
1.0p.M 
Percent stimu-
lation by iso-
proterenol 
1.0 p.M 
Normal (8)" 
0.19 ± 0.09 
0.96 ± 0.26 
496 
Atopic (5)(' 
0.36 ± 0.14 
1.46 ± 0.42 
a Reprinted from J Allergy Clin Immunol 53:284, 1974 
[15 ] 
b Each value represents mean ± SEM 
C Number of subjects studied 
d No difference from normal subjects 
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These studies are still incomplete but some inter-
esting results can be presented. 
Venous blood samples were obtained from adult 
patients with active atopic eczema. The only 
medication used by these patients at the time of 
study was topical steroid preparations. Blood 
which had been anticoagulated with ethylenedia-
mine tetraacetate (EDT A) was separated on a 
Ficoll-Hypaque gradient. The isolated lympho-
cytes were suspended in Medium 199 and incu-
bated with agonists for 20 min at 37° C in 5% CO 2 
and air. After incubation, the cells were harvested 
by centrifugation and the content of cAMP was 
assayed by a saturation assay method (Tab. III). 
The basal levels of cAMP in lymphocytes of the 
atopic subjects were normal but there was a 
diminished rise in intracellular levels of cAMP 
after stimulation with both isoproterenol and epi-
nephrine. Response to PGE 1 was normal. Cortisol 
increased the adenyl cyclase response to the agon-
ists in both normal and atopic subjects. In addi-
tion, incubation of lymphocytes in the presence of 
cortisol restored the response of the atopic lympho-
cytes to or above the level of normal cells without 
cortisol. The difference between normal and atopic 
adrenergic responses persisted in the presence of 
cortisol. 
We were interested in comparing the effects of 
the agonists on adenyl cyclase with their effects on 
a physiologic response. The response we chose to 
examine, glycogenolysis, was perhaps not the most 
interesting response but was one that can be 
simply and accurately quantitated. In this experi-
ment (Tab. IV) the changes in cAMP were paral-
leled by char.ges in glycogen content. The atopic 
patients had a diminished response to iso-
proterenol but not to PGE 1• These patients did not 
have evidence of serious impairment of lymphocyte 
function, however (unless elevated IgE is due to 
impaired function of a subpopulation of T -lym-
phocytes). Nine of the 10 atopic subjects had 
elevated IgE . Two of the subjects had decreased 
percentage of T -lymphocytes (sheep erythrocyte 
rosettes) but all had normal responses to phytohe-
magglutinin and concanavalin A. The percentage 
TABLE III. Comparison of cAMP content and adenyl cyclase response of lymphocytes of normal subjects and patients 
with atopic dermatitis 
Addition 
None (control) 
Isoproterenol 10- 5 M 
Epinephrine 10- 5 M 
PGE 1 , 10- 5 M 
Cortisol 10- 4 M 
Epinephrine + cortisol 
Prostaglandin + cortisol 
a Number of subjects studied 
b Percent of control (mean ± SEM) 
C Percent of values with cortisol alone 
cAMP (pmoles/106 cells) (mean ± SEM) 
Normal (16)a 
4.13 ± 0.80 
12.76 (309 ± 38)b 
14.46 (349 ± 51) 
27.35 (719 ± 62) 
6.90 ± 1.60 
28.90 (470 ± 59)C 
54.9 (971 ± 124) 
Atopic (lO)a 
5.11 ± 0.91 
10.53 (206 ± 20) 
9.71 (227 ± 35) 
24.53 (581 ± 97) 
7.60 ± 1.61 
21.54 (308 ± 46)C 
54.31 (698 ± 139) 
NS 
p < 0.05 
p < 0.05 
NS 
NS 
p < 0.05 
NS 
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TABLE IV. Comparison of adenyl cy clase responses and glycogenolysis in lymphocytes of normal subjects and patients 
with atopic dermatitis 
Glycogen % decrease 
(mean ± SE) cAMP pmole/ IO
B cells (mean ± SE) 
Addition 
Normal Atopic Normal Atopic 
None 3.31 ± 0.85 2.89 ± 0.58 
Isoproterenol 10- 7 M 7.28 ± 0.89 (120)Q 4.25 ± 0.62 (47) b 8.0 ± 3.2 5.9 ± 1.2 
10 - 5 M 8.41 ± 1.03 (154) 4.91 ± 0.66 (70) b 18.8 ± 5.2 5.4 ± LOb 
PGE 1 10- 7 M 8.44 ± 1.36 (155) 7.28 ± 1.53 (152) 7.11 ± 1.5 9.1 ± 1.6 
10 - 5 M 16.88 ± 2.02 (410) 17.11 ± 2.80 (492) 14.6 ± 1.6 11.7 ± 2 
Q Percent increase in parentheses 
b Difference between normal and atopic significant at 5% level 
of B-Iymphocytes (EAC rosettes) and response to 
pokeweed mitogen was normal in all. We have no 
information as yet about the beta adrenergic re-
sponse of the various lymphocyte subpopulations. 
Such information would be of great interest in view 
of the experiments of Tada et al [23 ] implicating an 
important suppressor role of thymic lymphocytes 
in IgE antibody production and the experiments of 
Bach [24] which indicate that thymocytes are 
especially responsive to isoproterenol and PGE 1 • 
Polymorphonuclear (PMN) leukocyte release of 
lysosomal enzymes and response to agonists were 
studied by the methods of Zurier et al [25] . The 
PMN cell fraction obtained from the Ficoll-
Hypaque centrifugation was freed of erythrocytes 
by ammonium chloride lysis suspended in Hanks ' 
salt solution in a final concentration of 3 x 106 
PMN/ml and incubated with zymosan and 20 % 
fresh autologous serum for 30 min. The reaction 
was terminated by centrifuging and the released 
lysosomal enzyme, beta-glucuronidase, was mea-
sured. The pharmacologic studies were conducted 
in the presence of 5 x 10- 4 M theophylline. There 
was slight inhibition of enzyme release with theo-
phylline alone but no difference was found between 
the control and eczema patients. The cells were 
incubated with PGE 1 for 30 min and with iso-
proterenol for 15 min prior to the addition of serum 
and zymosan. The asthma patients were adults 
who had not taken medication for at least 2 weeks 
prior to obtaining the blood samples. Granulocyte 
response to agonists is similar to lymphocytes. 
Granulocytes from the atopic subjects , both with 
asthma and with dermatitis, respond normally to 
prostaglandin but not to isoproterenol (Fig. 2). 
At the termination of the incubation, cAMP 
concentration of the cells was measured. Changes 
in cAMP were parallel to changes in lysosomal 
enzyme release (Tab. V). 
Several conclusions can be drawn . First, both 
lymphocytes and PMN leukocytes of patients with 
atopic dermatitis have a diminished response to 
beta agonists but a normal response to at least one 
other activator of adenyl cyclase, PGE 1 • Second, 
since both activation of adenyl cyclase and a 
subsequent physiologic response are normal with 
PGE 1 but impaired with beta agonists, the site of 
the impairment probably lies antecedent to activa-
0'0 Inhibition of Zymosan Induced Lysosomal Enzyme Release from 
PM" in Asthma and Eczema 
50% - Control (M=1\. (Mean :!: SEM) 
Asthm a (M= 17) ;;; 
Eczema (M=1\ ::{ 
25% -
o + 
10~M 10-6M 10-5M 10-7 M 10-6114 10-5M 10-( M 
Isoproterenol Prostaglandin El 
FIG. 2. Inhibition of zymosan-induced lysosomal en-
zyme , beta glucuronidase , released from PMN leukocytes 
in asthma and atopic dermatitis by isoproterenol and 
PGE 1 in the presence of theophylline at 5 x 10- 4 (mean 
± SEM). 
TABLE V. cAMP in granulocy tes 
Normal Eczema 
Drug (1.08 ± 35)a (1. 23 ± .63)° 
concent ration Isopro-Isoproterenol PGE, terenol PGE , 
10- 5 M 69b 279 14 262 
10- 6 M 44 270 15 246 
10 - 7 M 19 179 16 166 
Q Baseline (pmoles/ 10 6) . Mean ± SD (n = 10). 
b Percent increase in intracellular cAMP. Mean of 5 
experiments. 
tion of adenyl cyclase. This conclusion makes the 
assumption that beta agonists and prostaglandins 
stimulate the same adenyl cyclase, an assump-
tion that we consider reasonable for our studies on 
leukocytes since both agonists evoked the same 
ultimate physiologic response . 
There is considerable information available 
about adenyl cyclase, phosphodiesterases, and pro-
tein kinases of skin, although unfortunately these 
enzymes have not been studied in preparations 
containing a single cell type. The published data 
are consistent with the above conclusions. Mier 
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and Urselmann [26,27) found normal adenyl 
cyclase activities of homogenates of punch biopsies 
of skin from affected and normal-appearing areas 
of atopic dermatitis. The response of adenyl 
cyclase to adrenergic stimulation was lost during 
the process of homogenization so that the respon-
siveness to epinephrine of adenyl cyclase in mem-
brane preparations could not be investigated di-
rectly. Subsequently, Duell and her collaborators 
[28] were able to prepare a particulate fraction of 
epidermis that contained isoproterenol-sensitive 
adenyl cyclase but they did not compare adenyl 
cyclase of normal and atopic subjects. Phosphodi-
esterase activity and cAMP-dependent protein 
kinase activity are similar in biopsies taken from 
normal persons and patients with atopic dermati-
tis [29,30). Multiple forms of protein kinase occur 
in human skin [31] and the possibility of an 
abnormal distribution among these protein kinases 
cannot be excluded. However, because of the 
normal response to PGE 1 this possibility seems 
unlikely to account for the autonomic abnormality 
in atopic dermatitis. 
Turning now to the sequence of reactions leading 
up to the activation of adenyl cyclase, there are 
some observations implicating abnormalities of 
content and distribution of neurohumors in the 
skin. Scott [32] reported increased concentrations 
of acetylcholine in the lesions of atopic dermatitis. 
Presumably the increased acetylcholine existed in 
bound form within intraneuronal vesicles, for 
Scheidegger [33) reported increased amounts of 
acetylcholinesterase in the subpapillary plexus of 
the lesions. Solomon and Wentzel [34) found 
reduced plasma levels of epinephrine and nore-
pinephrine during acute episodes of atopic der-
matitis. Subsequently, Solomon et al [35] reported 
increased urinary excretion of radioactivity with 
deposition of radioactivity in the skin lesions after 
intravenous injection of [14C ]norepinephrine. A 
few patients with other skin diseases were included 
in the controls. No increased deposition of radioac-
tivity occurred in lesions of mycosis fungoides , 
syphilis, or acrosclerosis. 
Radioactivity persisted longer at the site of 
injection of [14C ]norepinephrine into the lesions 
of atopic dermatitis than into normal skin or 
lesions of mycosis fungoides, exfoliative dermati-
t is, psoriasis, contact dermatitis, or seborrheic 
dermatitis. By their nature these studies could not 
provide evidence on the cellular or subcellular 
location of norepinephrine nor even that the 14C 
label was still a valid measure of norepinephrine 
rather than a metabolite. Catechol-O-methyl 
t ransferase, the enzyme primarily responsible for 
extraneutonal degradation of epinephrine and nor-
epinephrine was found to be increased in lesions of 
atopic dermatitis [36). The relationship of in-
creased amounts of neurohumors and their degra-
dative enzymes in the skin to the mechanism of the 
rather specific reduction in response of the beta 
receptors of basal cells, lymphocytes, and granulo-
cytes of patients with atopic dermatitis remains to 
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be elucidated. Corticosteroids are the most effec-
tive agents for treatment of atopic dermatitis. It is 
of interest, therefore, that cortisol restored the 
response of atopic lymphocytes to isoproterenol. 
Despite the evidence reviewed in this paper, it 
should not be concluded that a simple decrease in 
response to beta stimulation accounts fully for 
abnormalities of atopic dermatitis. For one thing, 
if it did, topical isoproterenol or theophylline 
would be beneficial. They are not. 
SUMMARY 
Patients with atopic dermatitis have abnormal 
autonomic responses of the arterioles, pilomotor 
smooth muscle, and sweat glands. Their lesions 
have been reported to contain increased amounts 
of the neurohumors, acetylcholine and norepineph-
rine, as well as increased activity of acetylcholines-
terase and catechol-O-methyltransferase. In vitro 
studies of epidermis show that beta adrenergic 
agonists fail to evoke the normal inhibition of 
mitosis of basal cells of patients with atopic 
dermatitis. Epidermis removed not only from the 
lesions, but also from normal-appearing skin, re-
sponded abnormally. The increase in intracellular 
levels of cAMP after exposure to catecholamines 
was similar in normal and atopic epidermis. 
Lymphocytes and PMN leukocytes isolated from 
patients with atopic dermatitis show both a 
decreased physiologic response (glycogenolysis and 
inhibition of lysosome enzyme release) and a 
decreased rise in intracellular levels of cAMP upon 
incubation with beta agonists, but a normal re-
sponse to PGE 1 • Cortisol increases the response of 
lymphocyte adenyl cyclase to both agonists and, in 
the case of the patients with atopic disease, more 
than overcomes the depressed response to beta 
agonists. Because the leukocytes respond normally 
to PGE1 and because others have reported normal 
activities of skin adenyl cyclase, phosphodiester-
ase, and protein kinases, we conclude that the step 
responsible for the diminished beta adrenergic 
response lies antecedent to the catalytic site of 
adenyl cyclase. 
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DISCUSSION 
Austen: How do you rule out long-term effects of beta 
agonists on your results? 
Reed: One of the reasons we studied atopic patients 
with dermatitis rather than asthma was to eliminate the 
effects of treatment with adrenergic drugs on the in vitro 
responses to adrenergic stimulation . The patients in 
these studies had not received sympathomimetics and 
thus we are confident that the decreased adrenergic 
response is not due to treatment. 
Hanifin: Your epidermal cell function studies were 
done in autologous serum. Hopefully , later in the meeting 
we will be able to discuss atopic serum effects on 
leukocyte function . Have you done serum transpositions , 
i.e. , incubated normal epidermis in atopic serum and 
atopic epidermis in normal serum before doing your 
assays? 
Reed: Both the studies on epidermis and on leukocytes 
were performed in autologous serum. We have in progress 
experiments on the effect of atopic serum on normal cells; 
the results are only preliminary . It appears that the 
atopic serum may interfere with the adrenergic response 
of normal cells. 
Voorhees: The fact that isoproterenol and theophyl-
line don't ameliorate the disease may not say much about 
the possible importance of the cAMP system in eczema, 
because theophylline is a very poor phosphodiesterase 
inhibitor of the epidermal cAMP system. Also, you have 
no data on theophylline bioavailability from the cream. 
Furthermore, 3 years ago we found 14C catecholamines 
did not penetrate epidermis in an in vitro 2-cell percu-
taneous absorption system. 
Reed: We have no information about the availability 
of theophylline from the ointments. Two of the patients 
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treated with isoproterenol developed paroxysmal atrial 
tachycardia, so we assume it was well absorbed. 
Bystryn: There are real reasons to question whether 
atopic dermatitis is associated with increased vasocon-
strictor tone. Thus white dermographism is seen with all 
erythrodermas, regardless of their cause, and is not 
specifically associated with atopic dermatitis. The 
delayed blanch reaction to methacholine is associated 
with increased clearance of subcutaneously injected radi-
oactive tracers and increased pulsations of blood vessels , 
suggesting dilation rather than constriction of underlying 
arterioles. The underlying mechanism of blanching is 
probably not vasoconstriction but rather increased capil-
lary permeability causing localized accumulation of 
edema fluid. Lastly, studies of vasoconstrictor tone based 
on peripheral blood flow have given very variable results 
which may reflect change in threshold or reactivity rather 
than increase in vascular tone. 
Reed: Frankly, I find it difficult to believe that the 
blanching is due to edema. Blanching can be produced by 
iontophoresis of norepinephrine. There is no swelling, but 
pilomotor erection is prominent. The simple explanation 
is contraction of smooth muscle of vessels and hair 
follicles from alpha adrenergic stimulation. The evidence 
that the blanching is due to edema is derived from 
experiments of Colin Ramsay in which pulsation of the 
skin was recorded by reflection of a beam of light and 
could be interpreted as vasoconstriction of the superficial 
vessels but not of deeper vessels. Perhaps Dr. Mihm 
would comment. 
Mihm: The superficial loops that we have designated 
superficial capillary venules do not have a musculature 
and should not be contractile. Blanching is probably 
related to arteriolar vasoconstriction . 
Bystryn: It is sometimes difficult to deduce blood flow 
from skin color. The color of the skin is an index of the 
amount of blood in the subcapillary venous plexus and 
only indirectly of the degree of constriction and blood 
flow through underlying arterioles. The skin can blanch, 
as evidenced by the pallor of wheals in acute urticaria as 
a result of collapse or obscuration of the subcapillary 
venous plexus by extravascular fluid, in a situation where 
deeper dermal vessels are presumably dilated . 
McDevitt: I take it as generally accepted that atopic 
dermatitis shows a strong familial incidence, as well as a 
definite association with hayfever, asthma, and elevated 
IgE levels. 
In addition to family studies on association of atopy 
with one HL-A haplotype, I wonder if there have been 
any studies of genetic polymorphism for release of mast 
cell or basophil mediators, and for response to phar-
macologic agents. Lichtenstein has demonstrated a 
marked individual variation in mediator release from 
basophils. A genetic polymorphism might exist, should 
be looked for, and would affect the interpretation of your 
data, if it could be detected and analyzed in individual 
patients. 
Reed: I am not aware of studies on genetic influences 
on the responses of basophils or methacholine sensitivity 
of patients with atopic dermatitis. The atopic diathesis is 
generally considered to be familial and there is some 
evidence that the particular expression, asthma rhinitis 
or dermatitis, also tends to segregate within families . 
Increased sensitivity of the airways to methacholine does 
have a greater frequency in siblings of asthmatic sub-
jects, although the increased sensitivity is not necessarily 
concordant in identical twins [parker et al: Arch Intern 
Med 115:452, 1965]. 
